Cox Sharon E, Edwards Tansy, Faguer Benjamin N, Ferrer Julius P, Suzuki Shuichi J, Koh Mitsuki, Ferdous Farzana, Saludar Naomi R, Garfin Anna-Marie C G, Castro Mary C, Solon Juan A
Faculty of Epidemiology & Population Health, London School of Hygiene & Tropical Medicine, London, United Kingdom.
School of Tropical Medicine & Global Health, Nagasaki University, Nagasaki, Japan.
PLOS Glob Public Health. 2021 Nov 17;1(11):e0000011. doi: 10.1371/journal.pgph.0000011. eCollection 2021.
Diabetes and undernutrition are common risk factors for tuberculosis (TB), associated with poor treatment outcomes and exacerbated by TB. Limited data exist describing patterns and risk factors of multiple comorbidities in persons with TB. Nine-hundred participants (69.6% male) were enrolled in the Starting Anti-TB Treatment (St-ATT) cohort, including 133 (14.8%) initiating treatment for multi-drug resistant TB (MDR-TB). Comorbidities were defined as: diabetes, HbA1c ≥6.5% and/or on medication; hypertension, systolic blood pressure ≥140 mmHg or diastolic blood pressure ≥90 mmHg and/or on medication; anaemia (moderate/severe), haemoglobin <11g/dL; and, undernutrition (moderate/severe) body-mass-index <17 kg/m2. The most common comorbidities were undernutrition 23.4% (210/899), diabetes 22.5% (199/881), hypertension 19.0% (164/864) and anaemia 13.5% (121/899). Fifty-eight percent had ≥1 comorbid condition (496/847), with 17.1% having ≥2; most frequently diabetes and hypertension (N = 57, 6.7%). Just over half of diabetes (54.8%) and hypertension (54.9%) was previously undiagnosed. Poor glycemic control in those on medication (HbA1c≥8.0%) was common (N = 50/73, 68.5%). MDR-TB treatment was associated with increased odds of diabetes (Adjusted odds ratio (AOR) = 2.48, 95% CI: 1.55-3.95); but decreased odds of hypertension (AOR = 0.55, 95% CI: 0.39-0.78). HIV infection was only associated with anaemia (AOR = 4.51, 95% CI: 1.01-20.1). Previous TB treatment was associated with moderate/severe undernutrition (AOR = 1.98, 95% CI: 1.40-2.80), as was duration of TB-symptoms before starting treatment and household food insecurity. No associations for sex, alcohol or tobacco use were observed. MDR-TB treatment was marginally associated with having ≥2 comorbidities (OR = 1.52, 95% CI: 0.97-2.39). TB treatment programmes should plan for large proportions of persons requiring diagnosis and management of comorbidities with the potential to adversely affect TB treatment outcomes and quality of life. Dietary advice and nutritional management are components of comprehensive care for the above conditions as well as TB and should be included in planning of patient-centred services.
糖尿病和营养不良是结核病(TB)的常见危险因素,与治疗效果不佳相关,并会因结核病而加剧。关于结核病患者多种合并症的模式和危险因素的数据有限。900名参与者(69.6%为男性)被纳入开始抗结核治疗(St-ATT)队列,其中133人(14.8%)开始接受耐多药结核病(MDR-TB)治疗。合并症定义为:糖尿病,糖化血红蛋白(HbA1c)≥6.5%和/或正在接受药物治疗;高血压,收缩压≥140 mmHg或舒张压≥90 mmHg和/或正在接受药物治疗;贫血(中度/重度),血红蛋白<11g/dL;以及营养不良(中度/重度),体重指数<17 kg/m2。最常见的合并症是营养不良23.4%(210/899)、糖尿病22.5%(199/881)、高血压19.0%(164/864)和贫血13.5%(121/899)。58%的人患有≥1种合并症(496/847),17.1%的人患有≥2种合并症;最常见的是糖尿病和高血压(N = 57,6.7%)。超过一半的糖尿病患者(54.8%)和高血压患者(54.9%)之前未被诊断出。正在接受药物治疗的患者血糖控制不佳(HbA1c≥8.0%)很常见(N = 50/73,68.5%)。耐多药结核病治疗与糖尿病几率增加相关(调整优势比(AOR)= 2.48,95%置信区间:1.55 - 3.95);但高血压几率降低(AOR = 0.55,95%置信区间:0.39 - 0.78)。艾滋病毒感染仅与贫血相关(AOR = 4.51,95%置信区间:1.01 - 20.1)。既往结核病治疗与中度/重度营养不良相关(AOR = 1.98,95%置信区间:1.40 - 2.80),开始治疗前的结核病症状持续时间和家庭粮食不安全情况也与之相关。未观察到性别、饮酒或吸烟之间的关联。耐多药结核病治疗与患有≥2种合并症存在微弱关联(OR = 1.52,95%置信区间:0.97 - 2.39)。结核病治疗项目应针对很大一部分需要诊断和管理合并症的人群进行规划,这些合并症可能会对结核病治疗效果和生活质量产生不利影响。饮食建议和营养管理是针对上述情况以及结核病的综合护理的组成部分,应纳入以患者为中心的服务规划中。